Table 1.
Characteristics of all early-stage NSCLC patients with single tumor lesions undergoing SBRT and serial 18F-FMISO-PET imaging.
| Patient | Age | Gender | Histologic diagnosis | Stage (TNM) | Tumor diameter (cm) | Absolute vol. (cm3) | Tumor location | Max motion (mm) | Prescription dose | Completed all FMISO PET |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 78 | M | adenocarcinoma | stage IIA, cT2bN0M0 | 4.1 | 23 | right upper lobe | 8.8 | 18 Gy × 3 | No |
| 2 | 68 | M | squamous cell carcinoma | stage IA, cT1bN0M0 | 2.2 | 8 | left upper lobe | 4.8 | 18 Gy × 3 | Yes |
| 3 | 75 | M | adenocarcinoma | stage IA, pT1aN0 | 1.6 | 3 | left lower lobe | 12.4 | 18 Gy × 3 | Yes |
| 4 | 65 | F | non-biopsied (ground glass based on imaging appearance) | stage IA, pT1bN0 | 2.5 | 5 | right upper lobe | 4.4 | 18 Gy × 3 | Yes |
| 5 | 66 | M | non-biopsied | stage IA, pT1aN0 | 1.3 | 2 | right upper lobe | 2.6 | 18 Gy × 3 | Yes |
| 6 | 69 | M | squamous cell carcinoma | stage IIB, T3N0 | 5.3 | 94 | right lower lobe | 14.6 | 10 Gy × 5 | Yes |